Patents by Inventor Philip-John Lamey

Philip-John Lamey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent against periodontal disease
    Patent number: 7538087
    Abstract: The present invention relates to a product for preventing periodontal disease wherein the product includes or is based on a Cystatin type peptide. The invention also relates to dentifrice preparations including Cystatin and to medicaments including Cystatin for the treatment or prevention of periodontal disease and to the use of a nucleic acid sequence which encodes a Cystatin type peptide.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: May 26, 2009
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
  • Migraine and vasodilation treatment
    Patent number: 7396649
    Abstract: The present invention related to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in treating and preventing and treating migraine attacks.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: July 8, 2008
    Assignee: Philip-John Lamey
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
  • Agent against periodontal disease
    Publication number: 20040185012
    Abstract: The present invention relates to a product for preventing periodontal disease wherein the product includes or is based on a Cystatin type peptide. The invention also relates to dentifrice preparations including Cystatin and to medicaments including Cystatin for the treatment or prevention of periodontal disease and to the use of a nucleic acid sequence which encodes a Cystatin type peptide.
    Type: Application
    Filed: April 8, 2004
    Publication date: September 23, 2004
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
  • Migraine and vasodilation treatment
    Publication number: 20040092439
    Abstract: The present invention relates to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in preventing and treating migraine attacks.
    Type: Application
    Filed: February 26, 2003
    Publication date: May 13, 2004
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
  • Thermography as a method of measuring viral activity in a herpes labialis infection
    Patent number: 5666962
    Abstract: Disclosed is a non-invasive method of measuring the progress of viral activity in a mammalian herpes labialis episode, the method comprising the step of measuring the temperature of the symptomatic area of the herpes labialis episode during the episode. Also disclosed is a non-invasive method of preventing the clinical effects of a herpes labialis episode, the method comprising the steps of: measuring the temperature of the symptomatic area during the herpes labialis episode; and treating the herpes labialis episode with an effective amount of an antiviral agent sufficient to prevent a herpetic lesion.
    Type: Grant
    Filed: April 13, 1995
    Date of Patent: September 16, 1997
    Assignee: Warner-Lambert Company
    Inventor: Philip-John Lamey